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        Although a role for Foxp3-expressing regulatory 
T (T reg) cells in the maintenance of immune 
tolerance has been demonstrated in both humans 
and mice, the origin of these cells is still not 
completely understood. Early neonatal thymec-
tomy experiments in mice strongly suggested 
that T reg cells are generated in the thymus. 
Recent studies using Foxp3 reporter mice (  1  ) 
and transgenic mice that express foreign antigens 
in thymic tissue (  2, 3  ) have also traced the devel-
opment of Foxp3      cells to the thymus. 
  Aside from evidence that natural Foxp3      
T reg cells arise and mature in the thymus, there 
is mounting evidence that Foxp3      T reg cells can 
develop extrathymically under certain conditions. 
Both mouse (  4, 5  ) and human (  6  ) CD4     CD25    −    
T cells have been shown to express Foxp3      
and acquire suppressive activity in vitro after 
TCR stimulation in the presence of TGF-     . 
In vivo, delivery of subimmunogenic doses of 
antigen (  7  ), as well as endogenous expression 
of foreign antigen in a lymphopenic environ-
ment (  8  ), can also induce peripheral Foxp3      
T reg cell development. 
  Although results from these studies have 
provided promising therapeutic approaches, 
the occurrence of such conversion in an unma-
nipulated setting remains controversial. Previ-
ous works suggest that peripheral conversion 
does not occur under steady-state conditions or 
during infections (  9, 10  ). However, these stud-
ies failed to evaluate peripheral conversion at 
sites that require high levels of control, such as 
mucosal environments. 
  The gastrointestinal tract is in constant con-
tact with food proteins, commensals, and poten-
tially pathogenic microorganisms. To maintain 
immune homeostasis in this environment, the 
intestinal immune system has evolved redundant 
regulatory strategies. In this regard, the gut is 
home to a large number of regulatory T cells, 
including Foxp3      T reg cells. These cells play a 
central role in the control of intestinal homeo-
stasis (  11  ). Additionally, several subsets of DCs 
with regulatory properties have been described 
with the capacity to induce IL-10 secretion from 
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  To maintain immune homeostasis, the intestinal immune system has evolved redundant 
regulatory strategies. In this regard, the gut is home to a large number of regulatory T 
(T reg) cells, including the Foxp3     T reg cell. Therefore, we hypothesized that the gut 
environment preferentially supports extrathymic T reg cell development. We show that 
peripheral conversion of CD4     T cells to T reg cells occurs primarily in gut-associated 
lymphoid tissue (GALT) after oral exposure to antigen and in a lymphopenic environment. 
Dendritic cells (DCs) purifi  ed from the lamina propria (Lp; LpDCs) of the small intestine 
were found to promote a high level of T reg cell conversion relative to lymphoid organ  –
  derived DCs. This enhanced conversion by LpDCs was dependent on TGF-      and retinoic 
acid (RA), which is a vitamin A metabolite highly expressed in GALT. Together, these data 
demonstrate that the intestinal immune system has evolved a self-contained strategy to 
promote T reg cell neoconversion. 1776 FOXP3      T REG CELL INDUCTION BY GUT DENDRITIC CELLS | Sun et al.
Additionally, increased conversion in the Lp was statistically 
signifi  cant compared with the ear dermis (  Fig. 1 C  ). The GALT 
contains the largest number of lymphocytes in the body; 
thus, the absolute number of converted cells in the MLN 
or Lp was dramatically increased compared with other tissues 
(  Fig. 1 D  ). The number of converted cells found in the Lp 
was 18 times that found in the ear dermis and the number of 
converted cells in the MLN was 11  –  33 times that found in 
other LNs examined (  Fig. 1 D  ). Between 4 and 8 wk, the 
number of converted cells increased in the MLN and Lp, 
suggesting that there was continual conversion or accumulation 
of converted cells (Fig. S1 A, available at http://www.jem
.org/cgi/content/full/jem.20070663/DC1). Additionally, 
pheno  typic surface staining revealed that, in addition to CD25, 
in every tissue that we examined, converted T reg cells ex-
pressed high levels of the integrin chain CD103 (       E  ), a marker 
typically found in cells that have contacted epithelial surfaces 
(  Fig. 1, E and F,   and Fig. S1 B) (  20  ). 
  To confi  rm that cells converted in vivo were function-
ally regulatory T cells, we isolated CD4     eGFP      cells from 
RAG-1       /       mice that had been transferred with CD4     eGFP         
T cells 9 wk before (  Fig. 1 G  ). In vivo  –  converted CD4     eGFP      
T reg cells were able to suppress T  eff     proliferation as eff  ectively as 
freshly isolated CD4     eGFP      T reg cells (  Fig. 1 G  ). Together, 
these data indicate that under lymphopenic conditions, the 
GALT promotes peripheral conversion or accumulation of 
a population of functional T reg cells. 
  We next wanted to extend these fi  ndings to an immuno-
logically complete setting. Therefore, we used another transfer 
model, in which we adoptively transferred Ly5.2      T cells 
from RAG1       /       OT-II Tg mice, which are virtually devoid of 
Foxp3-expressing cells ( <  0.05%; unpublished data), into Ly5.1     -
  replete recipients. These recipients were then fed OVA antigen 
dissolved in drinking water for fi  ve consecutive days. This 
method allowed us not only to assess conversion in an immuno-
competent host but also to address the antigen-specifi  c require-
ments for in vivo conversion. Moreover, this protocol was 
previously demonstrated to suppress airway infl  ammation in a 
monoclonal setting via Foxp3 up-regulation (  21  ). 
  After 5 d of OVA administration, Ly5.2      OVA-specifi  c 
T cells had expanded and were readily detectable in the GALT, 
spleen, and in distal LNs, such as the subLN (  Fig. 2 A   and not 
depicted).   However, in spite of the dissemination of transferred 
cells, Foxp3     -expressing T cells were only appreciably detected 
in the GALT, including the MLN, Lp, and Peyer  ’  s patches 
(PPs;   Fig. 2 B  ). The highest frequency of Foxp3     -converted, 
OVA-specifi  c T cells was consistently found in the Lp, with a 
mean frequency of 16.8       6.5%. Translated into absolute num-
bers, the greatest number of Ly5.2      Foxp3      T cells was recov-
ered from the PPs, which had the highest increase in cellularity 
during OVA feeding (  Fig. 2 C  ). But in comparison to the 
spleen, statistically signifi  cant numbers of Ly5.2      Foxp3      T cells 
were also recovered from the MLN and Lp. Thus, after oral ex-
posure to antigen, the GALT and the small intestine, particularly 
Lp and PP, favor the conversion and/or accumulation of 
antigen-specifi  c Foxp3      T cells. 
T cells or induce oral tolerance at steady-state conditions 
(  12  –  14  ). Some eff  ects of gut-associated lymphoid tissue (GALT) 
DCs on mucosal immunity are associated with their capacity 
to synthesize a vitamin A metabolite, retinoic acid (RA). For 
instance, RA production by GALT DCs can selectively induce 
molecules, such as CCR9 and        4         7  , on conventional T cells 
and T reg cells involved in directing gut tropism (  15  –  17  ). RA 
has also been implicated in the modulation of B cell tropism 
and eff  ector functions by GALT DCs (  18  ). 
  We hypothesized that the gut environment, particularly 
small intestine lamina propria (Lp) DCs, could potentially me-
diate extrathymic T reg cell development. In this study, we 
demonstrate that peripheral conversion occurs primarily in the 
GALT after oral exposure to antigen in a replete host or in a 
lymphopenic environment. In vitro, DCs purifi  ed from the 
Lp of the small intestine promoted a high level of T reg cell 
conversion compared with DCs from the spleen. Enhanced 
conversion by LpDC was associated with the capacity of 
these cells to release RA. To our knowledge, these data provide 
the fi  rst evidence that DCs from a defi  ned environment can 
contribute to the generation of a pool of peripherally arising 
T reg cells under steady-state conditions. 
    RESULTS   
  Conversion or accumulation of converted Foxp3     T reg cells 
occur primarily in the GALT 
  The small intestinal tissue has been shown to constitutively 
express large amounts of TGF-      (  19  ) and is continuously 
exposed to gut fl  ora or dietary antigens. To specifi  cally de-
termine if the GALT could favor peripheral conversion, we 
used a lymphopenic mouse transfer model. To avoid Foxp3 
contamination in the initial Ly5.2      transfer population and to 
formally identify converted T reg cells, we used Foxp3  eGFP   
reporter mice. Specifi  cally, CD4      enhanced (e) GFP    –   (Ly5.2     ) 
T cells (3   ×   10  5  ) were adoptively transferred into recombination-
activating gene 1  –  defi  cient (RAG-1       /      ) hosts in conjunction 
with wild-type (wt) congenic (Ly5.1     ) CD4     CD25  hi   cells (10  5  ) 
to prevent concomitant autoimmunity. At each time point 
examined, from as early as 4 wk to as late as 17 wk after transfer, 
both populations of transferred T cells could be detected in 
all tissues examined and were maintained at similar levels across 
all tissues (  Fig. 1 A   and not depicted).   
  At 4 wk after transfer, Foxp3-expressing Ly5.2     CD4      
cells were detected as determined by eGFP fl  uorescence (  Fig. 
1 B and not depicted  ). Notably, the percentage of converted 
T reg cells was increased up to four to fi  ve times in the mes-
enteric LN (MLN) over other peripheral lymph nodes (pLNs) 
and was increased up to three times in the small intestinal Lp 
over other tissue sites, such as the ear dermis (  Fig. 1, B and C  ). 
Conversely, the naturally occurring (Ly5.1) T reg cells dis-
seminated in a nonpreferential manner to all tissues examined, 
indicating that the presence of converted cells was not an artifact 
of a potential contaminant in the initial transfer population 
(  Fig. 1 A  ). The percentage of increased conversion in the MLN 
was statistically signifi  cant compared with the submandibular 
LN (subLN) and to the inguinal LN (ingLN;   Fig. 1 C  ). JEM VOL. 204, August 6, 2007 
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  Figure 1.     Conversion or accumulation of converted Foxp3     CD4     T cells occurs primarily in the GALT. 4  –  17 wk after transfer of Ly5.1    CD4   CD25 hi  
T reg cells and Ly5.2    CD4   eGFP        T cells into RAG-1      /      hosts, T reg cell conversion was assessed in various tissues by surface staining and fl  ow cytometric 
analysis. (A) Homeostatic proliferation of Ly5.1      T reg cell cells and Ly5.2      cells was similar in all tissues examined. (B  –  D) Conversion of Ly5.2    eGFP        cells 
into eGFP      T reg cells occurred mainly in the MLN and LP, in both percentage (C) and total number (D) of cells. Data in A  –  D are from the 8-wk time point. 
The experiment was repeated at least four times with similar results. (E and F) CD25 and CD103 expression on converted eGFP      T cells in the MLN and LP. 
Cells gated on Ly5.2 and CD4 that express eGFP (E) also express CD25 and CD103 (F). Data in E and F are from the 17-wk time point and the experiment 
was repeated at least three times. (G) Converted eGFP      T reg cells are able to suppress T  eff   proliferation. Converted Ly5.2    eGFP     T reg cells were isolated 
from host peripheral LN and cultured in vitro with freshly isolated splenic DCs and peripheral LN CD4    eGFP        T eff   cells stimulated with     -CD3.  Freshly 
  isolated peripheral LN CD4    eGFP     T reg cells were used as controls. Suppressive function was assessed at a ratio of 1 T reg cell: 5 T  eff  . The representative 
experiment shown was performed twice, with identical results. Results of student  ’  s   t   test: *, P       0.05; **, P       0.001. Error bars represent the SD. 
  Characterization of LpDCs 
  Our observations suggested that the GALT microenvironment 
was particularly well suited for peripheral conversion of T reg 
cells. We next determined whether GALT DCs could contrib-
ute to peripheral conversion of T reg cells. We confi  rmed pre-
vious fi  ndings that DCs are plentiful in the intestinal Lp (  Fig. 
3 A  ) (  14, 22  ).   In contrast to the spleen, where DCs accounted 
for      3% of total cells, MHCII     CD11c      DCs comprised 10  – 
15% of all cells in Lp (  Fig. 3 A  ). As previously described (  23  ), 
LpDCs express a highly homogenous phenotype in which 1778 FOXP3      T REG CELL INDUCTION BY GUT DENDRITIC CELLS | Sun et al.
     80% are CD11b     , and no CD4 or CD8           DCs are detect-
able (unpublished data). In SpDCs, no CD103 was detected on 
CD11b      DCs and a low level of CD103 DCs were expressed 
on CD11b        DCs (  Fig. 3 A  ). In contrast, CD103 was highly ex-
pressed on 25% of CD11b      LpDCs (  Fig. 3 A  ). A similar popu-
lation has been previously described in the   colon Lp (  24  ). 
  After cell sorting, LpDCs displayed the characteristic fea-
tures of conventional DCs with a stellar shape comparable to 
freshly sorted SpDCs (  Fig. 3 B  ). LpDCs could also prime naive 
T cells as effi   ciently as SpDCs (unpublished data). Furthermore, 
although their levels of CD80 and CD86 were comparable, 
LpDCs expressed higher levels of MHC II and CD40 than 
SpDCs (  Fig. 3 C  ). 
  LpDCs convert Foxp3        T cells to Foxp3     T cells 
  We next examined whether LpDCs could induce T reg cell 
conversion. To this end, DCs from the Lp or spleen were 
isolated, cocultured with purifi  ed CD4     eGFP         T cells, and 
stimulated with      -CD3 mAb. Although      -CD3 did not in-
duce Foxp3 de novo, the addition of TGF-      resulted in T 
reg cell conversion in both cultures (  Fig. 4 A  ).   However, un-
der the same conditions and at several T cell to DC ratios, the 
frequency of converted Foxp3     CD4      T cells was up to 10-
fold higher in LpDC cultures (  Fig. 4 B  ). Notably, the level of 
expression of Foxp3 was higher when cells were converted in 
the presence of LpDCs than with SpDCs (mean fl  uorescence 
intensity [MFI] 90.9 vs. 57.4;   Fig. 4 A  ). Converted cells with 
Lp or SpDCs expressed high levels of CD25 and GITR 
(unpublished data). LpDCs also induced moderate, but con-
sistently higher, expression of the        E   chain (CD103) of the 
       E         7   integrin than SpDCs on converted T reg cells (59% 
[MFI 58.1] vs. 34.4% [MFI 43.2]), respectively (  Fig. 4 A  ). 
  To determine if these data were reproducible in an antigen-
specifi  c manner, we isolated naive T cells from OT-II TCR 
transgenic mice. Cocultures with OVA  p323-339   peptide-pulsed 
DCs produced similar results; with the addition of TGF-     , 
LpDCs induced 10-fold higher Foxp3 expression in OT-II T 
cells than in SpDCs (Fig. S2, available at http://www.jem.org/
cgi/content/full/jem.20070663/DC1). To determine if in 
vitro  –  converted T reg cells possessed suppressive activity, we 
isolated CD4      T cells based on eGFP expression and measured 
their ability to suppress T cell proliferation. Suppression by con-
verted T reg cells from both LpDCs and SpDCs cultures was at 
least as effi   cient as that of freshly isolated T reg cells (Fig. S3). 
  DCs expressing CD103 have been shown to display 
regulatory functions in a T cell transfer colitis model (  24  ). As 
  previously shown, 25% of LpDCs express CD103 (  Fig. 3 A  ). 
To determine if this subset favored T reg cell conversion, 
we further separated LpDCs based on CD103 expression. 
LpDCs, particularly CD103     LpDCs, were able to induce 
  Figure 2.     Foxp3 expression by RAG1      /      OT-II T cells in the GALT 
after oral administration of OVA protein. Ly5.2      RAG1     /      OT-II T cells 
were transferred into Ly5.1      recipient mice. Recipient mice were fed OVA 
antigen in drinking water for 5 d. On day 6, T reg cell conversion was 
assessed in various tissues by intracellular staining for Foxp3 and de-
tected via fl  ow cytometry. (A) After gating on CD4      T cells, transferred 
T cells in OVA antigen-fed mice were identifi  ed by Ly5.2 expression. Ly5.2     
cells were then assessed for intracellular Foxp3 expression. Detection 
of Foxp3      cells is illustrated for spleen (Sp), PP, and small intestinal Lp 
(bottom row). (B) Summary of the percentage of Ly5.2      RAG1     /      OT-II 
T cells expressing Foxp3. Each dot represents a single mouse. Data were 
combined from two individual experiments (three mice each). (C) Absolute 
number of Ly5.2    Foxp3     cells in OVA antigen-fed mice (     ) and nonfed 
control (     ). Error bars represent the SDs of the means of six individual 
samples from two combined experiments. Statistical comparisons were 
performed using the Student  ’  s   t   test, with Sp tissue serving as the base-
line comparison for each tissue. *, P       0.05; **, P       0.01; ***, P       0.001.   JEM VOL. 204, August 6, 2007 
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exogenous TGF-     , they remained much more potent than 
total SpDCs at inducing T reg cells in the presence of TGF-      
(  Fig. 4, A and C  ). 
  Stability of converted Foxp3     T reg cells 
  The relative paucity of converted T reg cells in SpDC co-
cultures could be caused by a lower viability or reduced pro-
liferative capacity of converted cells. To determine whether 
these elements were contributing to the outcome of con-
version in our assays, we examined the survival of in vitro  – 
activated T cells. In both SpDC and LpDC cocultures, con-
verted T reg cells remained signifi  cantly more viable than 
unconverted Foxp3         cells. Thus, the lower yield of T reg 
cells in SpDC cocultures was not the result of increased cell 
mortality (  Fig. 5 A  ).   We next explored the eff  ects of prolif-
eration on converted T reg cells. Because eGFP and CFSE 
share overlapping emission spectra, we isolated naive CD4      
T cells (Foxp3 contamination was      0.5%) from wt mice. 
Consistent with fi  ndings using CD4      T cells from reporter 
mice, the proportion of converted T reg cells continued to 
dominate in LpDC cocultures (54.5 vs. 14.9% for SpDC;   Fig. 
5 B  ). Moreover, Foxp3 expression, as assessed by anti-Foxp3 
antibody staining, was more intense when diff  erentiated in 
the presence of LpDCs (1,186 vs. 784 MFI;   Fig. 5 B  ). CFSE 
dilution profi  les indicated that CD4      T cells proliferated vig-
orously, regardless of the origin of DCs during the length of 
incubation. Yet, even at late division cycles, the proportion 
of converted T reg cells remained high in LpDC   cocultures 
(  Fig. 5 C  ). These data suggested an initiation of a more stable 
Foxp3      T reg cell program in the presence of LpDCs. 
  RA produced by LpDC is responsible for conversion 
of Foxp3     T cells 
  We further explored the mechanism underlying enhanced 
conversion in LpDC cocultures. Several reports have demon-
strated that lymphocytes activated in the presence of GALT 
LpDCs selectively up-regulate the gut-homing surface mole-
cules CCR9 and        4         7  , resulting in their preferential migration 
into intestinal tissue (  15, 16, 18, 25  ). This up-regulation was 
recently shown to depend on RA (  18, 26  ). Consistent with 
these reports, we observed up-regulated        4         7   expression on 
converted Foxp3      T reg cells in LpDC, but not in SpDC, 
cocultures (  Fig. 6 A  ).   Next, we asked whether RA was able to 
exert an enhancing eff  ect on T reg cell conversion. To test this, 
we incubated SpDCs with      -CD3 and TGF-      in the presence 
of increasing doses of the synthetic RA, all-trans RA. Although 
RA alone did not induce Foxp3 expression, RA in the presence 
of TGF-      enhanced T reg cell conversion and up-regulated 
       4         7   (  Fig. 6 B   and not   depicted). At low RA concentrations 
(1 nM), T reg cell conversion increased by      50% in SpDC 
cocultures (from 16.4 to 27.4%). The enhanced conversion by 
RA plateaued above concentrations of 10 nM, with the per-
centage of Foxp3      cells reaching 40  –  55% (  Fig. 6 B  ). 
  The addition of RA in the presence of TGF-      to LpDC 
cocultures also increased the proportion of converted cells 
and diminished the intrinsic diff  erences in each subset  ’  s ability 
Foxp3 expression in the absence of exogenous TGF-      
(  Fig. 4 C  ). Such conversion was dramatically enhanced in 
presence of TGF-      (  Fig. 4 C  ). Although CD103        LpDCs 
failed to induce Foxp3 expression de novo in the absence of 
  Figure 3.     Phenotype of SpDCs and LpDCs. (A) Total spleen cells and Lp 
cells were stained with      -MHCII,      − CD11c,      − CD103  and     -CD11b  mAb. 
(top) The percentages of CD11c    MHCII     cells. (bottom) CD103 versus CD11b 
expression on CD11c    MHC  II     gated events. Numbers represent the percent-
age of events in each quadrant. (B) Giemsa staining of sorted spleen (left) 
and Lp (right) CD11c    MHCII     DCs. Bar, 15      m. (C) Expression of MHC II, 
CD40, CD80, and CD86 of spleen DC (thick line) and LpDC (thin line) were 
analyzed on CD11c    MHCII     cells. Dotted line represents the corresponding 
isotype control. Data are from one of at least three independent experiments.     1780 FOXP3      T REG CELL INDUCTION BY GUT DENDRITIC CELLS | Sun et al.
we added the synthetic RA receptor antagonists LE540 and 
LE135 (RAi) to block RA signaling in T cells. Remarkably, 
the addition of 1      M each of these inhibitors inhibited T reg 
cell conversion by 67 and 57% in CD103      and CD103         LpDC 
cocultures, respectively (  Fig. 6 C  ). Collectively, these data 
suggest that RA signaling by LpDCs synergize with TGF-      
to favor T reg cell conversion. In support of this,        –  TGF-      
and RAi signifi  cantly decreased spontaneous      -CD3  –  induced 
conversion by CD103      LpDCs (87%, P       0.0005, and 73%, 
P       0.001, respectively;   Fig. 6 D  ). 
    DISCUSSION   
  In this study, we provide evidence that the GALT environ-
ment favors de novo Foxp3      T reg cell conversion. We also 
to induce T reg cell conversion (  Fig. 6 C  ). Interestingly, in 
cultures in which conversion is already high (as with CD103      
LpDC) RA has a more dramatic eff  ect on        4         7   than on Foxp3 
expression. This suggests that the amount of RA required 
for Foxp3 expression may be lower than that required for 
up-regulation of        4         7  . Because CD103      LpDCs consistently 
induced low levels of T reg cell conversion in cocultures 
containing      -CD3 alone, we tested whether exogenous RA 
would improve conversion. However, exogenous RA, in the 
absence of TGF-     , failed to increase the frequency of 
Foxp3      T reg cells (unpublished data). 
  Together, our data suggested that RA from LpDCs might 
be, in part, responsible for the enhanced T reg cell conver-
sion observed in LpDC coculture. To address this hypothesis, 
  Figure 4.     Intestinal DCs induce Foxp3 expression of effector T cells with higher effi  ciency than splenic DC. (A) 10  5   Foxp3        cells were cultured 
with 2       10 4   splenic or LpDCs for 5 d with      -CD3 mAb alone or combined with TGF-     . Plots are gated on CD4      cells, and the percentages of Foxp3      cells 
are shown. Phenotypic analysis of converted T reg cells is shown on the right. 5-d cultured cells from A were stained for CD4 and CD103. Histogram 
shows the CD103 expression of CD4    Foxp3     cells cultured with SpDCs (thick line) or LpDCs (thin line). (B) 10  5   Foxp3      CD4     T cells cultured with DCs and 
     -CD3 mAb and TGF-      as in (A) for 5 d, with the ratio of T/DC as 5/1, 10/1, 20/1 or 40/1. Data are the mean       SD of triplicate wells. (C) Foxp3         cells  were 
cultured as in A with CD103     LpDC or CD103        LpDC. Plots are gated on CD4      cells and Foxp3 versus      4     7   stainings are shown. The numbers indicate 
  percentage of events in each quadrant. Data are from one of at least three independent experiments.     JEM VOL. 204, August 6, 2007 
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antigens, while maintaining the capacity to mount powerful 
immune responses against pathogens. This property, referred 
to as oral tolerance, can be associated with the induction 
of TGF-       –  producing Th2-like cells (Th3 cells), peripheral 
deletion, or Ag-specifi  c T reg cells (  21, 27  ). Studies have 
demonstrated that repeated Ag feeding induced Ag-specifi  c 
Foxp3      T reg cells in the absence of natural T reg cells (  21  ). 
We confi  rmed these fi  ndings in complete mice that received 
Foxp3         OT-II T cells and were placed on a similar OVA 
feeding regimen. In our model, converted cells were rap-
idly found in the MLNs, PPs, and particularly in the small 
intestine Lp, in which 17% of antigen-specifi  c T cells were 
Foxp3     . Considering the amount of antigens persistently 
present in the lumen of the intestine, these data suggest that 
peripheral conversion may represent a signifi  cant pathway 
for the generation of Foxp3      T cells. Although some PPDC 
subsets possess unique immunoregulatory properties, we 
have yet to examine the conversion capacity of DCs from 
reveal that DCs from the Lp of the small intestine have the 
unique ability to generate T reg cells in vitro via a mechanism 
that, in addition to TGF-     , is dependent on the vitamin A 
metabolite RA. 
  Our hypothesis that LpDCs could mediate Foxp3      
T reg cell diff  erentiation is supported by our adoptive trans-
fer studies, which indicate that peripheral conversion occurs 
preferentially in the GALT and/or associated tissue. We fi  rst 
observed T reg cell conversion in a lymphopenic transfer set-
ting via eGFP expression in T cells possessing a Foxp3 bicis-
tronic eGFP reporter construct. This system allowed us to 
isolate and transfer pure T cell populations devoid of Foxp3. 
Though our fi  ndings diff  er from another study that showed 
that transferred Foxp3         reporter cells into lymphopenic hosts 
did not express Foxp3 de novo (  9  ), on several counts our 
fi  ndings were similar. We also found that Foxp3      T reg cell 
conversion was marginal in the pLN and spleen (  9  ). The fact 
that the authors observed no conversion in the MLN may 
refl  ect the transfer model used, where CD4     Foxp3         T cells 
were transferred into lymphopenic hosts without the cotrans-
fer of T reg cells. Consequently, the development of massive 
infl  ammation in the large bowel under these conditions may 
have led to a redistribution of converted T reg cells away 
from the MLN. Remarkably, the intestinal immune system 
tolerates repeated exposure to resident microfl  ora and food 
  Figure 5.     Maintenance of Foxp3 contributes to higher frequency 
of Foxp3    CD4     T cells in the presence of LpDC. (A) eGFP       CD4     T  cells 
were cocultured with purifi  ed DC at a 5:1 ratio with      -CD3 and TGF-    .  At 
indicated time points, cells were harvested and stained for CD4, Class II, 
and 7-AAD. Foxp3 expression was determined based on eGFP fl  uores-
cence. The percentage of viable cells is depicted by open bars for LpDC 
and fi  lled bars for SpDC. Data are from one of two independent experi-
ments. (B) CFSE-labeled naive CD4      T cells were cocultured with purifi  ed 
DCs as described in A. On day 5, cells were harvested and stained for 
CD4 and intracellular Foxp3. Illustrated are dot plots of Foxp3 versus 
CFSE. The percentage of Foxp3      cells and the MFI was defi  ned as the 
bordered population. (C) In cultures containing LpDC (         ) or SpDC (      ) 
the proportion of Foxp3      cells among CD4 T cells is plotted as a function 
of the number of cell divisions. Data are representative of three indepen-
dent experiments.     
  Figure 6.     RA production by LpDC is requisite for optimal Foxp3     
T reg cell conversion. Foxp3         CD4 T cells were cocultured with DC at a 
10:1 ratio as described in   Fig 4  . (A) Cells were stained for      4     7   and  as-
sessed for eGFP fl  uorescence (Foxp3) by fl  ow cytometry. Results are repre-
sentative of three independent experiments. (B) The dose responsiveness 
of all-trans RA on eGFP (Foxp3) expression by CD4 T cells cocultured with 
SpDC was determined by fl  ow cytometry. Error bars represent the SDs of 
the means of three individual samples from one experiment. Statistical 
signifi  cance was determined using the Student  ’  s   t   test. *, P       0.05; 
**, P       0.01; ***, P       0.001. Results are representative of three independent 
experiments. (C) Foxp3         CD4     T cells were cocultured with CD103      or 
CD103         DC at a 10:1 ratio as described in   Fig 4  . Cells were stained for 
     4     7   and the effect of 100 nM RA, or the RA receptor inhibitors LE540 
and LE135 on (eGFP) Foxp3 expression was determined by fl  ow cytometry. 
Results are representative of three independent experiments. (D) Foxp3        
CD4 T cells were cocultured with CD103      DC in the presence of     -CD3  or 
     -CD3 in combination with TGF-      neutralizing antibody (isotype IgG1) or 
LE540 and LE135. eGFP (Foxp3) expression was determined by fl  ow 
cytometry. NS. Error bars represent the SD from the means of three inde-
pendent experiments. ***, P       0.001.   1782 FOXP3      T REG CELL INDUCTION BY GUT DENDRITIC CELLS | Sun et al.
the integrity of the intestinal epithelial barrier but also pre-
vents the proper deployment of eff  ector lymphocytes into 
the GALT after priming (  18, 26, 32  ). Indeed, the GALT is a 
signifi  cant producer of RA in the body, based on the abun-
dance of RA-synthesizing enzymes present in the epithelia 
and certain resident DC populations (  26  ). The precise factors 
that govern the activation of some of these enzymes have yet 
to be clarifi  ed. More recently, it was demonstrated that RA 
and cytokines produced by DCs in the Peyer  ’  s patches syner-
gized to promote IgA secretion by gut-activated B cells (  18  ). 
Importantly, a recent study demonstrated that the addition of 
RA to naturally occurring T reg cells in vitro can promote 
their expression of gut tropism receptors and, subsequently, 
favor their migration to the GALT (  17  ). Consistent with this 
observation, we present in vitro results that suggest that RA 
from LpDCs synergizes with TGF-      to induce strong extra-
thymic T reg cell conversion. First, LpDCs, but not SpDCs, 
induced the integrin heterodimer        4         7  , which is a hallmark 
of RA signaling (  26  ), on converted T reg cells. Second, the 
levels of        4         7  , which were highest in cocultures containing 
CD103      LpDCs, correlated strongly with the degree of 
conversion. But perhaps most compelling was the dramatic 
increase in T reg cell conversion upon addition of syn-
thetic RA to SpDC cocultures, and the decrease of con-
verted T reg cells when nuclear RA signaling was blocked 
in LpDC cocultures. 
  Although RAi signifi   cantly inhibited      -CD3  –  induced 
conversion by CD103      LpDCs, RA alone is not suffi   cient for 
Foxp3      T reg cell conversion. In the absence of exogenous 
TGF-     , RA failed to induce T reg cells in SpDC cocultures 
(unpublished data). Moreover, RA also failed to enhance the 
basal level of conversion observed in CD103      LpDC cocul-
tures. These fi  ndings support the idea that RA acts to en-
hance signals delivered by TGF-      and that TGF-     , but not 
RA, is the limiting factor in CD103      LpDC-induced con-
version. Notably, we did not observe a reduction in T reg 
cell priming by LpDCs upon treatment with citral, which is 
an inhibitor of RALDH that is involved in the oxidation of 
retinal to RA (unpublished data). We therefore favor the hy-
pothesis that RA is being released from prestored pools. Pre-
vious studies demonstrated that RA can also manipulate DC 
functions (  14  ). Thus, Foxp3 induction by RA may be the 
consequence of a direct action on T cells or via an autocrine 
conditioning of LpDC functions. 
  The cooperation observed between GALT-derived TGF-      
and RA in the optimal production of T reg cells in our in vitro 
system, also fi  ts particularly well with our in vivo fi  ndings, 
in which peripherally converted cells are detected predomi-
nantly in the LP and MLN. From these data, we postulate 
that the intestinal immune system, through the simultaneous 
production of TGF-      and RA, has evolved a self-contained 
strategy to promote neoconversion. This dual requirement 
would prevent spontaneous de novo conversion in other 
peripheral compartments and further explains the unique ca-
pacity of the gut to induce tolerogenic outcomes. Enhanced 
TGF-       –  mediated conversion in the presence of RA also 
the PPs (  12  ). Nevertheless, our fi  ndings indicate that LpDCs 
are quite competent inducers of T reg cells in vitro. Previ-
ous work demonstrated that small intestinal LpDCs not only 
presented orally administered Ag, but also suppressed delayed 
type hypersensitivity responses (  14  ). Further supporting a 
role for LpDCs in T reg cell conversion are fi  ndings that 
the MLNs are crucial for oral tolerance induction, and that 
a signifi  cant proportion of CD103      DCs, which we found 
potently induced T reg cell conversion, enter the MLN from 
the Lp (  16, 28  ). 
  Apart from their T reg cell  –  inducing capacity, DCs from 
the small intestinal Lp retain several immunoregulatory fea-
tures, e.g., constitutive expression of IL-10 (  14  ). Some of 
these features may have been infl  uenced by conditioning sig-
nals received from noninfl  ammatory cytokines constitutively 
produced by the intestinal epithelia. These cytokines include 
TGF-      and the Th2 response driving thymic stromal lym-
phopoietin (TSLP) (  19, 29  ). Intriguingly, a recent study dem-
onstrated that TSLP from human epithelial cells was involved 
in the thymic induction of Foxp3      T reg cells (  30  ). However, 
our examination of TSLP receptor –  defi  cient mice (TSLPR      /      ) 
revealed no alterations in the frequency and absolute number 
of T reg cells across several lymphoid and nonlymphoid tissues 
(not depicted). Moreover, we noted no intrinsic diff  erences 
between LpDCs from TSLPR       /       and wt mice to induce 
T reg cell conversion in vitro (Fig. S4, available at http://
www.jem.org/cgi/content/full/jem.20070663/DC1). Con-
versely, TGF-      exerted a strong infl  uence on the induction of 
T reg cell conversion in our system. Virtually every work de-
tailing the extrathymic generation of CD25      or Foxp3      T reg 
cells thus far, both in vitro and in vivo, has noted the critical 
involvement of TGF-      in this process (  4, 6, 7, 9  ). 
  TGF-      is also known to play a positive role in the induc-
tion of the integrin CD103 (  31  ). Importantly, a large propor-
tion of DCs present in the colon and MLN express CD103 
and were found to be crucial for protection from pathology 
in a mouse transfer model of colitis (  24  ). Another study found 
that the majority of LpDCs express CD103 (  16  ). In untreated 
mice, we found a smaller, but still appreciable (    25%) popu-
lation of CD103      LpDCs. These CD103      induced Foxp3      
T reg cell conversion in the absence of exogenously added 
TGF-     . Endogenous TGF-      was responsible for T reg cell 
conversion, as neutralizing antibodies to TGF-      largely ab-
lated T reg cell conversion. Cumulatively, these fi  ndings sug-
gest a critical role for CD103      DCs in the maintenance of gut 
homeostasis. How these DCs respond to intestinal infl  amma-
tion in response to infection and whether their ability to in-
duce conversion can be altered remains to be addressed. Yet, 
TGF-      cannot explain, in full, how these populations of DCs 
induce Foxp3      because the addition of a relatively high dose 
of exogenous TGF-      to SpDC cocultures still induced sig-
nifi  cantly less conversion compared with LpDC cocultures. 
  It is becoming clear that nutrient status can impact an in-
dividual  ’  s susceptibility to intestinal pathologies (  32  ). In the 
case of vitamin A, and in particular, its transcriptionally active 
metabolite, RA, prolonged insuffi   ciency not only disrupts JEM VOL. 204, August 6, 2007 
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MLN, and Lp were removed from RAG-1       /       hosts to assess cell conver-
sion. LN single-cell suspensions were prepared by passing tissue through a 
70-     m cell strainer. Ear dermis cells were prepared as previously described 
(  35  ). For Lp cells, small intestinal segments were treated with medium con-
taining 3% FCS and 20 mM Hepes (HyClone) for 20 min at 37  °  C with 
constant stirring. Tissue was further digested with 250 mg/ml liberase CI 
(Roche) and 500 mg/ml DNase I (Sigma-Aldrich), with continuous stirring 
at 37     C for 30 min. Digested tissue was forced through a Cellector tissue 
sieve, (Bellco Glass, Inc.) and passed through 70- and 40-     m cell strainers. 
Lymphocytes were further enriched by centrifugation at room temperature 
at 500   g   for 20 min in 30% Percoll (GE Healthcare) in RPMI-1640. All cells 
were incubated with antibodies to Ly5.2 (104), CD4, CD25, CD103 (2E7; 
all from eBioscience) and assessed for the expression of these markers in ad-
dition to eGFP by fl  ow cytometry on an LSRII (BD Biosciences). In some 
experiments, in vivo  –  converted CD4     eGFP      cells pooled from all periph-
eral LNs were purifi  ed based on eGFP expression by fl  ow cytometry on 
a FACSVantage or FACSAria and assessed for their suppressive capacity 
in vitro. 
  Oral antigen administration.     T lymphocytes were extracted from the 
secondary LNs (excluding the spleen) of RAG1       /       OT-II Tg mice (Ly5.2) 
and adoptively transferred into B6.SJL recipient mice (Ly5.1). Each mouse 
received 10  6   cells. Recipient mice were then divided into two groups, with 
one group receiving a 1.5% OVA solution dissolved in drinking water that 
was replaced every 48 h (grade V; Sigma-Aldrich) for 5 consecutive days, 
and another receiving normal drinking water. On day 6, subLNs, MLNs, 
PPs, and Lps were collected from B6.SJL hosts, and Foxp3 expression was 
assessed in transferred cells. LN and LP single-cell suspensions were prepared 
as described in the previous section. 
  Suppression assays.     T reg cell ability to suppress T cell proliferation was 
determined as previously reported (  36  ). In brief, CD4     GFP      T reg cells 
were cultured in 96-well fl  at-bottom plates (Costar) with 5       10  4   freshly 
isolated CD4     GFP         T cells used as eff  ectors. For antigen-presenting cells, 
splenocytes were depleted of CD90      cells by isolation kit and autoMACs 
(Miltenyi Biotec), irradiated, and cultured at 10  5   per well. Cells were stimu-
lated with 0.5      g/ml      -CD3 (145-2C11) mAb (BD Biosciences) for 72 h at 
37     C/5% CO  2  . Cultures were pulsed with [  3  H]TdR (MP Biomedicals) at 
1      Ci/well for the last 8 h. All experiments were performed in duplicate or 
triplicate, cell yield permitting. 
  DC purifi  cation.     For LpDCs, total Lp cells after digestion with Liberase 
CI were passed through 70- and 40-     m cell strainers. Cells were resus-
pended in 1.077 g/cm  3   iso-osmotic NycoPrep medium (Accurate Chemical 
  &   Scientifi  c Corp.), and the low-density fraction was collected after centrif-
ugation at 1,650   g   for 15 min. Nycodenz gradient excludes debris and red 
blood cells and decreases lymphocyte numbers without changing the com-
position of the diff  erent subsets of LpDC (Fig. S5, available at http://www
.jem.org/cgi/content/full/jem.20070663/DC1). Cells were washed and 
incubated with a mixture of mAb containing        −  CD11c (HL-3),        −  MHC II 
(AF6-120.1),        −  CD16/32 (2.4G2), and        −  CD103 mAb (2E7), as well as 
the non-DC components        −  DX5 (DX5),      -NK1.1 (PK136), and        −  B220 
(RA3-6B2, all from eBioscience). DCs were defi  ned as CD11c     MHCII      
cells and non-DCs were excluded when sorted by fl  ow cytometry on a 
FACSVantage or FACSAria. In some experiments, CD103      and CD103         
DCs were separated. Purity was verifi  ed by fl  ow cytometry on a FACS-
Calibur. I-A  b   CD11c      cells were      90%. 
  For SpDCs, spleens were cut into fragments and digested by 100 mg/ml 
Liberase CI and 150 mg/ml DNase I, and then dissociated in Ca  2   -free me-
dium in the presence of EDTA. IA  b   CD11c      SpDCs were further purifi  ed 
for LpDCs, resulting in     98% purity. For phenotypic analysis, I-A  b   CD11c      
DCs were stained with fl  uorescent dye-conjugated      -CD11b (M1/70), 
     -CD103 (2E7; all from eBioscience),      -CD40 (3/23),      -CD80 (16-10A) (  1  ), 
and      -CD86 (GL-1; all from BD Biosciences) mAb and analyzed by fl  ow 
cytometry on a FACSCalibur or LSR II (BD Biosciences). 
suggests that the use of vitamin A and associated precursors 
and metabolites in chemoprevention clinical trials may need 
to be reevaluated depending on the tissue of target. In sev-
eral clinical trials,      -carotene  –   and retinol (vitamin A)-based 
therapies resulted in the exacerbation of lung cancer (  33  ). 
Nevertheless, these results do not necessarily negate the po-
tential for treating discrete sites of acute or chronic infl  amma-
tion with infusions of RA. 
  Using our in vitro system, we further found that T reg 
cells generated in the presence of LpDCs possessed higher 
Foxp3 expression and up-regulated the tissue-homing integ-
rins CD103 and        4         7   in comparison to T reg cells generated 
in the presence of SpDCs. These fi  ndings may be harnessed 
to generate or expand T reg cells with specifi  c homing 
features to target tissue pathology that occurs in diseases 
where the epithelia or intestine are aff  ected, while preventing 
global suppression. 
  In summary, we propose that our in vivo and in vitro data 
are highly relevant to a variety of situations in which de novo 
T reg cell conversion may be necessary. First, the GALT and 
its associated tissues are often considered to be in a state of 
physiological activation, and thus poised to control patho-
genic microbial invasion (  34  ). A system to generate T reg cells 
in this region ensures their rapid deployment when intestinal 
homeostasis is threatened. Moreover, as the thymus and gut 
likely maintain a degree of nonoverlapping antigen reper-
toires, it is plausible that T reg cells conversion in the GALT 
potentially expands the T reg cell repertoire. 
  In some instances, T reg cell levels have to be limited to 
favor effi   cient immune responses, whereas in other cases, 
such levels must be increased to limit immunopathology. 
Manipulation of T reg cell numbers or functions off  ers prom-
ising therapeutic avenues. Together, our results suggest that 
manipulation of RA metabolism or the use of RA could be-
come part of a rational strategy to manipulate the ratio between 
T reg cells and eff  ector cells. 
    MATERIALS AND METHODS   
  Mice.     C57BL/6, B6.SJL, OT-II TCR transgenic mice Ly5.2     , and OT-II 
transgenic RAG-1       /       mice were purchased from Taconic Farms. Foxp3 
eGFP reporter mice (Foxp3  GFP  ) were originally obtained from M. Oukka 
(Brigham and Women’s Hospital, Cambridge, MA) (  5  ). All mice were 
maintained at an American Association for the Accreditation of Laboratory 
Animal Care  –  accredited animal facility at the National Institute for Allergy 
and Infectious Diseases (NIAID) and housed in accordance with the proce-
dures outlined in the Guide for the Care and Use of Laboratory Animals 
under an animal study proposal approved by the NIAID Animal Care and 
Use Committee. 
  In vivo cell transfer.     Purifi  ed CD4     eGFP         (3       10  5  ) and CD4     CD25  hi   
(10  5  ) from peripheral LNs were transferred intravenously into RAG-1       /       
mice, and the ability of CD4     GFP         cells to convert into CD4     eGFP      cells 
was assessed 4  –  17 wk later. Specifi  cally, single-cell suspensions of peripheral 
LNs from either Foxp3  eGFP   or congenic B6.SJL mice were enriched for 
CD4      T cells by a negative selection kit using an autoMACs (Miltenyi Biotec). 
CD4     Foxp3  eGFP   T cells or congenic CD4      T cells were further labeled 
with fl  uorescent dye  –  conjugated mAb (CD4, RM4-5; CD25, 7D4; eBio-
science) and sorted by fl  ow cytometry on a FACSVantage or FACSAria 
(BD Biosciences). 4  –  17 wk after transfer, the ear dermis, subLN, ingLN, 1784 FOXP3      T REG CELL INDUCTION BY GUT DENDRITIC CELLS | Sun et al.
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  In vitro conversion assay.     Our conversion protocol was performed as pre-
viously described (  5  ), with the following modifi  cations. 10  5   CD4     eGFP    –    
T cells or CD4     CD25        CD62L     CD44    –    naive T cells from wt or OT-II mice 
were cultured with 2.5       10  3    –  2       10  4   purifi  ed Lp or SpDCs in 250      l of 
complete medium (RPMI-1640 containing 10% FBS, 2       10    −  5   M of 2ME, 
100      g/ml of penicillin, and 100      g/ml of streptomycin) with soluble 1      g/ml 
       −  CD3 mAb (BD Biosciences) and human 3 ng/ml rTGF-      (Cell Science, 
Canton, MA) for 5 d. The precise ratio of T cells to DCs used is provided in 
the text. In some experiments, the following were included in the coculture 
conditions: (a) all-trans RA (Sigma-Aldrich) at varying concentrations; (b) RA 
receptor       inhibitors LE540 (Wako Chemicals USA) and LE135 (Tocris 
Bioscience), each at 1      M; and (c)      -TGF-      mAb (1D11.16.8) or isotype 
control mAb MOPC (31C; both from American Type Culture Collection) at 
10      g/ml. 5 ng/ml human rIL-2 (Peprotech) was added to cultures wells 
every other day beginning on day 2. On day 5, cells were stained with PE-
Cy7  –  conjugated      -CD4 mAb (RM4-5), and Foxp3      cells were detected 
either by eGFP expression and/or FITC/PB-conjugated      -Foxp3 intracellular 
mAb (FJK-16; both from eBioscience) in accordance with the manufacturer  ’  s 
protocol on a FACSCalibur or LSRII. For viability assays, cultured cells were 
additionally stained with 7-amino-actinomycin D (7-AAD; BD Biosciences) 
to detect dead cells. For phenotypic analysis, eGFP     CD4      cells were further 
stained for      -CD103 (2E7) or      -       4         7   (DATK32; BD Biosciences) mAb, 
       −  CD25 (PC61.5; eBioscience), and 7-AAD. Live cells were analyzed by 
fl  ow cytometry on a FACSCalibur or LSR II (BD Biosciences). 
  In vitro proliferation assay.     FACS-purifi  ed CD4     CD25        CD44         T cells 
from wt mice were labeled with 1.25      M CFSE (Invitrogen) in PBS for 
5 min at room temperature. Cells were washed twice in media containing 
3% FBS and cultured in 2       10  4   purifi  ed Lp or SpDCs. 
  Statistical analysis.     Groups were compared with Prism software (Graph-
Pad) using the unpaired or paired Student  ’  s   t   test. 
  Online supplemental material.     Fig. S1 shows that the number of con-
verted cells increases in the MLN and Lp and that all converted cells express 
CD103. Fig. S2 shows that LpDC can convert OTII CD4 Foxp3  T cells 
into Foxp3  T cells in the presence of peptide and TGF-     . Fig. S3 shows 
that converted T reg cells are as suppressive as naturally occurring T reg cells 
in vitro. Fig. S4 shows that Nycodenz gradient does not change LpDC sub-
sets. Fig. S5 shows that LpDCs do not require TSLP conditioning signals to 
induce Foxp3 T reg cell conversion. 
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